BSG and hepatocellular carcinoma: Many studies illustrate the role of metabolic-related pathways in HCC progression; for instance, CD147, which is overexpressed in many cancers, influences tumor progression by promoting the reprogramming of fatty acid metabolism (Li et al., 2015).